dijous, 29 de gener del 2015

TAVI: Medtronic CoreValve study shows benefits for CABG patients




Patients who've already had coronary artery bypass graft surgery showed a significant mortality benefit with Medtronic's CoreValve replacement heart valve than with open heart surgery, according to a clinical trial.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uGeAtC

1 comentari: